AZN vs CWAN · P/E 28, $288.38B cap vs P/E 13, rev $451.8M
AstraZeneca PLC (AZN) versus Clearwater Analytics Holdings Inc (CWAN) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Clearwater Analytics Holdings Inc (CWAN) is a software - application company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported CWAN revenue for 2024-12-31 was $451.8M. Net income was $427.6M. Revenue was up 22.7% from 2023-12-31 to 2024-12-31. CWAN currently screens at market cap $6.34B and trailing P/E 13.2.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. CWAN currently screens at market cap $6.34B and trailing P/E 13.2.
Not investment advice. Open the AZN and CWAN stock pages for the full models.
Not investment advice.